The OA Trial Bank: meta-analysis of individual patient data from knee and hip osteoarthritis trials show that patients with severe pain exhibit greater benefit from intra-articular glucocorticoids.

MLA

van Middelkoop, M., et al. “The OA Trial Bank: Meta-Analysis of Individual Patient Data from Knee and Hip Osteoarthritis Trials Show That Patients with Severe Pain Exhibit Greater Benefit from Intra-Articular Glucocorticoids.” Osteoarthritis and Cartilage, vol. 24, no. 7, July 2016, pp. 1143–52. EBSCOhost, https://doi.org/10.1016/j.joca.2016.01.983.

APA

van Middelkoop, M., Arden, N. K., Atchia, I., Birrell, F., Chao, J., Rezende, M. U., Lambert, R. G. W., Ravaud, P., Bijlsma, J. W., Doherty, M., Dziedzic, K. S., Lohmander, L. S., McAlindon, T. E., Zhang, W., & Bierma-Zeinstra, S. M. A. (2016). The OA Trial Bank: meta-analysis of individual patient data from knee and hip osteoarthritis trials show that patients with severe pain exhibit greater benefit from intra-articular glucocorticoids. Osteoarthritis and Cartilage, 24(7), 1143–1152. https://doi.org/10.1016/j.joca.2016.01.983

Chicago

van Middelkoop, M, N K Arden, I Atchia, F Birrell, J Chao, M U Rezende, R G W Lambert, et al. 2016. “The OA Trial Bank: Meta-Analysis of Individual Patient Data from Knee and Hip Osteoarthritis Trials Show That Patients with Severe Pain Exhibit Greater Benefit from Intra-Articular Glucocorticoids.” Osteoarthritis and Cartilage 24 (7): 1143–52. doi:10.1016/j.joca.2016.01.983.